Michael Barbella, Managing Editor08.22.23
Bioretec Ltd. has refined and expanded its Scientific Advisory Board (SAB) to further strengthen its strategic focus areas.
The company has assembled key opinion leaders to represent expertise from the refocused RemeOs portfolio. The SAB members specialize in orthopedic trauma (Prof. Dr. Klaus Dresing, Germany; and Prof. Dr. Fan Liu, China), foot and ankle surgery (Prof. Dr. Stefan Rammelt, Germany; and Dr. Robert Leland, U.S.), pediatric orthopedic trauma (Prof. Dr. Theddy Slongo, Switzerland; and Dr. Verena Schreiber, U.S.) and spine surgery (Prof. Dr. Jeffrey Wang, U.S.; and Dr. Richard Assaker, France). The surgeons will help guide the company's processes in clinical product development, education and training programs, and engaging surgeon communities.
"It is critical for Bioretec to have gained the support of key opinion leaders in different disciplines. We are therefore very honored that such a distinguished group of surgeons trust Bioretec and our new RemeOs product line to set a new standard in the orthopedic industry," Bioretec CEO Timo Lehtonen said. "By harnessing the collective expertise of the SAB, Bioretec aims to achieve the capability to drive significant improvements in clinical performance and patient experience. Their combined expertise and vision align seamlessly with Bioretec's mission to improve patient's quality of life through innovative orthopedic solutions."
Bioretec has tapped Dresing to serve as board chairman. He is a former vice director of the Department of Trauma Surgery, Orthopedics, and Plastic Surgery at Göttingen University Medical Center in Germany. Dresign has held numerous leadership positions in AO Foundation.
Liu is chief and professor in the Department of Orthopedic Surgery at the Affiliated Hospital to Nantong University in China, and is vice president of both the Chinese Orthopedic Association and the Chinese Association of Orthopedic Surgeons.
Rammelt is professor and head of the Foot & Ankle Section, University Center of Orthopaedics & Traumatology, University Hospital Carl Gustav Carus, in Dresden, Germany. He is also president of the German Society of Biomaterials and vice president of the German Foot & Ankle Society.
Leland is clinical assistant professor in the Department of Orthopedics at the University of Colorado. He is also a member of the Colorado Medical Society, American Orthopaedic Foot and Ankle Society, American Academy of Orthopaedic Surgeons, and AO Alumni.
Schreiber is a pediatric orthopedic surgeon at the Nicklaus Children's Hospital Orthopedic, Sports Health, and Spine Institute in Miami. She is a member of the Pediatric Orthopaedic Society of North America, Orthopaedic Research Society, Orthopaedic Trauma Association, American Academy of Orthopaedic Surgeons (AAOS), and the American Academy for Cerebral Palsy and Developmental Medicine.
Slongo is head of Pediatric Surgery and Child Traumatology at University Hospital in Bern, Switzerland. He is a member and founder of AO Foundation's Pediatric Expert Group and chairman of the AO Foundation's External Fixator expert group.
Wang is professor of Orthopedic Surgery and Neurosurgery, and co-director of the USC Spine Center in Los Angeles. His numerous leadership roles in international medical organizations include AO Spine, the North American Spine Society (NASS), the Cervical Spine Research Society, and AAOS. Wang also is a Second Medical Opinion physician with the National Hockey League (NHL), and the National Hockey League Players' Association (NHLPA).
Assaker is professor of Neurosurgery at CHRU Lille, Hôpital Salengro in Lille, France. He is a member of the French Society of Neurosurgery, the French Society of Spine Surgery, Spine Societies of Europe SSE, NASS, the International Educational Committee of NASS, and chairman of the international education residents program.
Bioretec's RemeOs product line offers a breakthrough solution that combines the benefits of biodegradability, implant strength, and performance. The technology ensures effective treatment but also eliminates the need for subsequent implant removal surgeries, thereby enhancing patient comfort and reducing healthcare costs, according to Bioretec. RemeOs is based on a magnesium alloy and hybrid composite; the implants are resorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The combination has the potential to make titanium implants redundant. The company has received U.S. regulatory approval for its first RemeOs product, and CE mark authorization is expected sometime this year.
The Scientific Advisory Board will work closely with Bioretec's executive team, contributing their perspectives and knowledge to advance the company's research, development, and clinical strategies. Their collective insights, combined with their influence within the medical community, will empower Bioretec to push the boundaries of orthopedic innovation.
Bioretec is a Finnish medical device company that develops biodegradable orthopedic implants. The company has built competencies in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The products developed and manufactured by Bioretec are used worldwide in approximately 40 countries.
[
The company has assembled key opinion leaders to represent expertise from the refocused RemeOs portfolio. The SAB members specialize in orthopedic trauma (Prof. Dr. Klaus Dresing, Germany; and Prof. Dr. Fan Liu, China), foot and ankle surgery (Prof. Dr. Stefan Rammelt, Germany; and Dr. Robert Leland, U.S.), pediatric orthopedic trauma (Prof. Dr. Theddy Slongo, Switzerland; and Dr. Verena Schreiber, U.S.) and spine surgery (Prof. Dr. Jeffrey Wang, U.S.; and Dr. Richard Assaker, France). The surgeons will help guide the company's processes in clinical product development, education and training programs, and engaging surgeon communities.
"It is critical for Bioretec to have gained the support of key opinion leaders in different disciplines. We are therefore very honored that such a distinguished group of surgeons trust Bioretec and our new RemeOs product line to set a new standard in the orthopedic industry," Bioretec CEO Timo Lehtonen said. "By harnessing the collective expertise of the SAB, Bioretec aims to achieve the capability to drive significant improvements in clinical performance and patient experience. Their combined expertise and vision align seamlessly with Bioretec's mission to improve patient's quality of life through innovative orthopedic solutions."
Bioretec has tapped Dresing to serve as board chairman. He is a former vice director of the Department of Trauma Surgery, Orthopedics, and Plastic Surgery at Göttingen University Medical Center in Germany. Dresign has held numerous leadership positions in AO Foundation.
Liu is chief and professor in the Department of Orthopedic Surgery at the Affiliated Hospital to Nantong University in China, and is vice president of both the Chinese Orthopedic Association and the Chinese Association of Orthopedic Surgeons.
Rammelt is professor and head of the Foot & Ankle Section, University Center of Orthopaedics & Traumatology, University Hospital Carl Gustav Carus, in Dresden, Germany. He is also president of the German Society of Biomaterials and vice president of the German Foot & Ankle Society.
Leland is clinical assistant professor in the Department of Orthopedics at the University of Colorado. He is also a member of the Colorado Medical Society, American Orthopaedic Foot and Ankle Society, American Academy of Orthopaedic Surgeons, and AO Alumni.
Schreiber is a pediatric orthopedic surgeon at the Nicklaus Children's Hospital Orthopedic, Sports Health, and Spine Institute in Miami. She is a member of the Pediatric Orthopaedic Society of North America, Orthopaedic Research Society, Orthopaedic Trauma Association, American Academy of Orthopaedic Surgeons (AAOS), and the American Academy for Cerebral Palsy and Developmental Medicine.
Slongo is head of Pediatric Surgery and Child Traumatology at University Hospital in Bern, Switzerland. He is a member and founder of AO Foundation's Pediatric Expert Group and chairman of the AO Foundation's External Fixator expert group.
Wang is professor of Orthopedic Surgery and Neurosurgery, and co-director of the USC Spine Center in Los Angeles. His numerous leadership roles in international medical organizations include AO Spine, the North American Spine Society (NASS), the Cervical Spine Research Society, and AAOS. Wang also is a Second Medical Opinion physician with the National Hockey League (NHL), and the National Hockey League Players' Association (NHLPA).
Assaker is professor of Neurosurgery at CHRU Lille, Hôpital Salengro in Lille, France. He is a member of the French Society of Neurosurgery, the French Society of Spine Surgery, Spine Societies of Europe SSE, NASS, the International Educational Committee of NASS, and chairman of the international education residents program.
Bioretec's RemeOs product line offers a breakthrough solution that combines the benefits of biodegradability, implant strength, and performance. The technology ensures effective treatment but also eliminates the need for subsequent implant removal surgeries, thereby enhancing patient comfort and reducing healthcare costs, according to Bioretec. RemeOs is based on a magnesium alloy and hybrid composite; the implants are resorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The combination has the potential to make titanium implants redundant. The company has received U.S. regulatory approval for its first RemeOs product, and CE mark authorization is expected sometime this year.
The Scientific Advisory Board will work closely with Bioretec's executive team, contributing their perspectives and knowledge to advance the company's research, development, and clinical strategies. Their collective insights, combined with their influence within the medical community, will empower Bioretec to push the boundaries of orthopedic innovation.
Bioretec is a Finnish medical device company that develops biodegradable orthopedic implants. The company has built competencies in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The products developed and manufactured by Bioretec are used worldwide in approximately 40 countries.
[